Skip to main content
. 2022 Oct 30;75(3):523–530. doi: 10.1007/s13304-022-01404-4

Table 1.

Demographics of patients undergoing pancreaticoduodenectomy stratified by delayed gastric emptying

DGE No DGE
Characteristic (n = 1246) (n = 6765) P value
 Age, year, median (IQR) 69.0 (61, 75) 67.0 (60, 73)  < 0.001
 Male, n (%) 773 (62.0%) 3522 (52.1%)  < 0.001
Comorbidities, n (%)
 Hypertension 707 (56.7%) 3563 (52.7%) 0.008
 Diabetes mellitus 350 (28.1%) 1916 (28.3%) 0.867
 Weight loss 233 (18.7%) 1325 (19.6%) 0.468
 Smoker 193 (15.5%) 1197 (17.7%) 0.059
 COPD 80 (6.4%) 264 (3.9%)  < 0.001
 Ascites 8 (0.6%) 17 (0.3%) 0.023
 Bleeding disorder 41 (3.3%) 198 (2.9%) 0.488
 Steroid 31 (2.5%) 148 (2.2%) 0.510
 Congestive heart failure 2 (0.2%) 30 (0.4%) 0.146
 End-stage-renal disease 2 (0.2%) 8 (0.1%) 0.698
Functional health status prior to surgery, n (%)
Independent 1231 (98.8%) 6713 (99.2%) 0.308
Partially dependent 1 (0.9%) 1 (0.6%) 0.308
Totally dependent 1 (0.1%) 1 (0.0%) 0.308
Preoperative obstructive jaundice, n (%) 703 (56.4%) 3858 (57.0%) 0.919
Chemotherapy within 90 days, n (%) 293 (23.5%) 1976 (29.2%)  < 0.001
Radiation therapy within 90 days, n (%) 125 (10.0%) 839 (12.4%) 0.006

DGE Delayed Gastric Emptying, IQR interquartile range, COPD chronic obstructive pulmonary disease